[SRNE] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
09-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 47.48%
YoY- 23.15%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 11,461 13,511 9,007 6,477 3,913 4,665 902 52.72%
PBT -220,599 -167,340 -82,213 -70,654 -74,081 -16,137 -46,113 29.79%
Tax -1,050 -641 -1,919 -383 -1,377 -1,398 -1,164 -1.70%
NP -219,549 -166,615 -77,740 -56,762 -73,864 -14,187 -44,949 30.24%
Tax Rate - - - - - - - -
Total Cost 231,010 180,126 86,747 63,239 77,777 18,852 45,851 30.91%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -1,915.62 -1,233.18 -863.11 -876.36 -1,887.66 -304.12 -4,983.26 -14.72%
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.55 -0.57 -0.36 -0.46 -0.73 -0.20 -0.97 -9.01%
EPS Diluted -0.55 -0.57 -0.36 -0.43 -0.73 -0.20 -0.97 -9.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.